Archeon Medical and Ambu announce their collaboration for distribution of EOlife and EOlifeX

February 21, 2025 12:00 AM AEDT | By EIN Presswire
 Archeon Medical and Ambu announce their collaboration for distribution of EOlife and EOlifeX
Image source: EIN Presswire
NEW-YORK, NY, UNITED STATES, February 20, 2025 /EINPresswire.com/ -- Archeon Medical, a pioneer in life-saving medical devices, and Ambu, a world-renowned leader in healthcare solutions, proudly announce a strategic partnership that promises to reshape the landscape of manual ventilation in the U.S. healthcare market. This collaboration will bring Archeon Medical's revolutionary EOlife devices to the forefront of emergency care, setting new standards for patient safety and intervention efficiency.

EOlife are revolutionary devices designed to significantly enhance the quality of manual ventilations during cardiopulmonary resuscitation (CPR). For the first time, caregivers can get real-time feedback on tidal volume and ventilation frequency, enabling healthcare professionals and emergency first responders to administer life-saving care with greater precision. EOlife addresses critical challenges in CPR, such as under (hypo) or over (hyper) ventilation, ensuring optimal oxygen delivery to patients and ultimately, enabling more lives to be saved from cardio-respiratory arrest.

In 1956, Ambu introduced the world’s first self-inflating resuscitator, the Ambu® Bag™, developed in collaboration with anesthesiologist Henning Ruben and still in use today. This device — the first portable, self-inflating manual resuscitation device that worked without a battery or an oxygen supply — became a fundamental tool in hospitals and emergency services worldwide and has remained the gold standard in resuscitation devices.

“We’re thrilled to partner with Ambu in North America, a company whose legacy and expertise in manual ventilation are unparalleled,” said Valentine Oqda, Head of U.S. Operations at Archeon Medical . Alban De Luca, CEO and Co-founder of Archeon Medical, added “This partnership perfectly aligns the strength of two pioneering companies: Ambu, whose products have been a staple in the medical world for over 68 years, and Archeon, whose breakthrough technology has already earned over 15 international awards despite our young existence. Together, we are ready to transform how emergency care is delivered.”

“Ambu’s partnership with Archeon Medical is a natural fit given our shared mission of improving the quality of manual ventilation and resulting patient outcomes,” said Allan Jensen, Ambu’s Vice President of Sales in North America. “We view Archeon Medical as a leading innovator in this space and are excited to team up with them to achieve this mutual goal.”


About Ambu
Since 1937, Ambu has been rethinking medical solutions to save lives and improve patient care. Millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions.
In the past, we provided a way to maintain or restore breathing in any environment with the world’s first self-inflating resuscitator, the Ambu® Bag™, which is still in use today. More recently, we responded to a need for an endoscopy solution that is always available. The result? Ambu® aScope™, the world’s first sterile, single-use flexible endoscope.
Today, we continue to collaborate with leading medical experts to deliver innovations that make a real difference to healthcare professionals and their patients.
At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America and the Asia Pacific, 4,500+ team members keep Ambu moving forward.

About Archeon Medical
With their headquarters in Besançon, France, Archeon Medical was founded by Alban De Luca and Pierre-Edouard Saillard and has been revolutionizing the practice of emergency manual ventilation since 2018.
Archeon Medical developed the groundbreaking EOlife range of Ventilation Feedback Devices to enable emergency healthcare responders to deliver safe, effective and guideline compliant manual ventilations to cardio-pulmonary arrest patients.
Today, EOlife devices are used around the world in both educational and clinical arenas and are fast becoming the new gold standard in emergency manual ventilation delivery.


Ambu
Jeff Derr
Director, Marketing Communications
[email protected]
www.ambuusa.com

Archeon Medical
Alice Nicolas
Communication Director
[email protected]
www.archeon-medical.com

Alice Nicolas
Archeon Medical
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.